Objective: Cerebral embolization during trans-catheter aortic valve implantation (TAVI) has not been assessed clearly in the literature. Therefore, we compared the rate of cerebral embolisms with diffusion-weighted magnetic resonance imaging (DWI) in transfemoral (TF) and trans-apical (TA) approaches. Method: Eighty patients benefited from TAVI between January 2008 and June 2010. Out of these, 35 were included in the study. Twenty-one were TF (group 1) and 14 TA (group 2). During the same period, 285 patients benefited from a conventional aortic valve surgery (aortic valve replacement (AVR)). Thirteen of these were also analyzed and considered as the control group (group 3). We systematically performed a DWI the day before the procedure and 48 h after. DWI studies were blindly analyzed by a neuroradiologist, and all patients had a clinical neurological assessment before and after the procedure, according the National Institutes of Health Stroke Scale (NIHSS). Results: Thirtytwo patients in the TAVI group had new cerebral lesions: 19 in the TF group and 13 in the trans-apical group ( p = NS). Mean number of embolic lesions per patient was 6.6 in group I and 6.0 in group II ( p = NS). Mean volume of embolic lesions was 475.0 mm 3 in group I and 2170.5 mm 3 in group II ( p = NS). In group III, one patient had one new cerebral lesion ( p < 0.05 vs TAVI) of 36.5 mm 3 ( p = NS vs TAVI). All patients were neurologically asymptomatic. Conclusions: The incidence of silent cerebral embolic lesions after TAVI is significantly higher compared with the standard surgical AVR. The number of emboli is similar in the TF and TA groups but the volume tended to be higher in the TA group. However, there is no clinical impact of those lesions. #
Introduction
Cardiac surgery is increasingly performed on elderly patients. This population has more co-morbidities such as impaired ventricular function, coronary disease, peripheral vascular disease and renal insufficiency. These co-morbid factors have been described as independent factors of mortality in this older population [1] .
Neurological complication is a dramatic postoperative event, especially in this population with poor life expectancy [2, 3] . Indeed, cerebral damage after conventional aortic valve replacement (AVR) ranges from 0.21% to 2.0% for neurological death rate and from 1.1% to 6.6% for clinical stroke rate [4, 5] . Therefore, from 1.1% to 6.6% (transcatheter aortic valve implantation, TAVI) was first proposed to this very frail population with the expectancy to decrease the mortality and morbidity related with the procedure.
Magnetic resonance imaging (MRI), and especially diffusion-weighted imaging (DWI), is nowadays the most powerful tool for diagnosing acute ischemic brain lesions, and has become a surrogate marker for clinical and sub-clinical brain embolism [6] . DWI has already been used to evaluate the incidence of silent infarcts after angiographic procedures and carotid endarterectomy or stenting [7] .
Therefore, we analyzed clinical and sub-clinical brain embolism by DWI in a single-center, prospective, nonrandomized study to evaluate per procedural embolic events in patients undergoing TAVI. We compared the cerebral embolic events between the transfemoral (TF) and the transapical (TA) approach. We also compared the TAVI group to a conventional AVR group.
Materials and methods
From January 2008 to June 2010, we performed 355 isolated aortic valve surgery. Eighty were TAVI procedure using Edwards Sapiens (Edwards Lifesciences Inc, Irvine, CA, USA) and 275 were conventional AVR.
The TAVI were divided as 50 TF and 30 TA. All patients were screened for inclusion into this prospective study. Exclusion criteria were: carotid artery stenosis >70% on duplex, presence of permanent pacemaker or defibrillator, patients who refused to participate in the study. Indication for TAVI was in concordance with the recent consensus statement [8] .
Concomitantly, we included in the study 13 patients undergoing conventional AVR defined as the control group (CG). Patients' characteristics are listed in Table 1 .
The study population was divided in three groups: group 1 TF, group 2 TA, and group 3 CG.
Cerebral DWI was performed in patients 24 h before implantation. For group 1 and 2 post-procedural DWI was performed after 48 h, and for group 3 after 72-96 h because of the external pacemaker leads.
The systematic clinical neurological examination was assessed following a standardized protocol according to the National Institutes of Health Stroke Scale (NIHSS) before and after implantation.
MRI protocol
A standardized protocol using fast spin echo-fluid attenuated inversion recovery sequence (FSE-FLAIR) and diffusion-weighted-spin echo-echo planar imaging (DWI SE-EPI) was applied in all patients before and after the procedure. The MR examination was performed at 1.5T (NT-Philips Healthcare or Intera-Philips Healthcare) in five patients in group 1, five in group 2, and one in group 3. The other patients were examined at 3T (Intera-Philips Healthcare or Verio-Siemens). The DWI sequence consisted of an initial T2-weighted acquisition followed by a second acquisition with the application of diffusion-sensitizing gradients in the three orthogonal directions with a b factor = 1000 s mm (Philips) or 1.3 Â 1.6 mm 2 (Siemens) were obtained. One neuroradiologist blinded to the surgical protocol reviewed all MR examinations and rated the DWI trace images for the presence of acute ischemic parenchymal damage. Lesions were quantified using the following scoring system: number of lesions, location according to the vascular territory (anterior, middle, posterior cerebral arteries, or vertebrobasilar arteries), side and cortical versus subcortical or deep gray matter. Moreover, a planimetry of each lesion was performed by manual contouring, and the lesion volume was calculated by multiplying the surface by the slice thickness and slice gap.
TAVI procedure
The Edwards Sapiens (Edwards Lifesciences Inc, Irvine, CA, USA) valve consists of a tri-leaflet bioprosthetic bovine pericardial tissue valve mounted and sutured in a balloonexpandable stainless-steel frame. The TF technique was performed as described by Cribier [9] . The TA technique was performed as described previously by Walther [10] , and modified by our team [11] .
Conventional AVR procedure
All conventional patients were operated by median sternotomy under classical cardiopulmonary bypass. Arterial cannulation was performed in the ascending aorta and venous cannulation in the right atrium. Myocardial protection was achieved with an intermittent antegrade warm blood cardioplegia every 15 min. Valve implantation was realized with a pledget below the annulus suture.
Statistical analysis
Descriptive statistics were performed using Statistical Package for Social Sciences (SPSS) statistical software. A pvalue less than 0.05 was considered significant. Continuous variables are presented as mean AE standard deviation. Oneway analysis of variance (ANOVA) was used to compare continuous variables between the three groups.
To analyze the relationships between the embolic cerebral lesions and type of procedure, we used two strategies. In a first strategy, we used negative binomial regression to model the relationships between the number of embolic cerebral lesions and type of procedure, taking confounders into account. Negative binomial regression was preferred over Poisson regression because of observed overdispersion (variance > mean). The SAS procedure GENMOD was used.
In a second strategy, we used logistic regression to model a binary variable (presence of absence of embolic cerebral lesion). Type of procedure was introduced in the form of dummy variables; other covariates were not transformed. The SAS procedure LOGISTIC was used. SAS procedures were run under SunOS (SAS 9.1 release).
Results
Forty-eight patients completed cerebral DWI pre-and postoperatively. Procedural success for valve implantation was 100% for all three groups.
Clinical results
Neurological examination after the procedure was similar to the neurological examination prior to the procedure in all patients. None of them had a clinical neurological deficit.
DWI results
Of the 48 patients, 33 had new embolic cerebral lesions. The median (mean, SD) number of lesions were four (mean = 5.9, SD = 6.8) in group 1, 4.5 (mean = 6.6, SD = 7.1) in group 2, and 0 (mean = 0.08, SD = 0.28) in group 3.
Attack rate (presence of new lesions/number of patients) was 90% in group 1 (19/21), 93% in group 2 (13/14), and 8% in group 3 (1/13).
The mean number of emboli per patient was 6.0 in group 1, 6.6 in group 2 and 0.1 in group 3 (group 1 vs 3: p = 0.02; group 2 vs 3: p = 0.01 and group 1 vs 2: p = NS).
The mean volume of ischemic lesion was 475.0 mm 3 in group 1, 2170.5 mm 3 in group 2, and 36.5 mm 3 in group 3 (group 1 vs 2 vs 3: p = NS).
The majority of the lesions were located in the left brain (Fig. 1) . The new embolic lesions were located in supra-(superficial) and infra-tentorial (deep) regions.
Negative binomial regression adjusted for age and European System for Cardiac Operative Risk Evaluation (EuroSCORE) showed that type of lesion was significantly associated with the number of lesions. In comparison with group 3, parameter estimate of group 1 was 3.2 (standard error = 1.09, chi-square = 8.55, p = 0.0035) and parameter estimate of group 2 was 3.4 (standard error = 1.09, chisquare = 9.67, p = 0.0019). EuroSCORE was not significantly associated with the number of events, while age was positively associated.
Logistic regression resulted in similar associations. In comparison with groups 1 and 2, group 3 was strongly associated with the presence of lesions: parameter estimate = À4.85, standard error = 1.2, Wald chi-square = 16.3, p < 0.0001, and odds ratio (OR) = 0.008 (95% confidence limits = 0.001 and 0.083). No other variable was significantly associated with the presence of lesions once group 3 was in the regression model. Model fit was quite acceptable according to likelihood ratio and Hosmer-Lemeshow statistics.
As it can be seen, both strategies led to similar parameter estimates indicating a strong association of TA and TF procedures with new embolic lesions, as compared with the surgical approach.
Discussion
This study confirms that silent neurological lesions occur more often after TAVI than after conventional AVR. None of the patients with embolism were symptomatic.
However, in this study, we performed a standard neurological motricity examination before and after the procedure; we did not performed fine neurocognitive testing. Barber described in 2008 [12] that, after cardiac surgery, 63% had embolic events on cerebral DWI. Of those 5% had a clinical stroke, but neurocognitive decline was observed on cerebral DWI in 100% of patients who had silent embolic events. We strongly believe that neurosensitive testing is mandatory in further studies.
Recent articles reported a clinical stroke rate after TAVI less than 72% [13, 14] . In this study, there was no incidence of clinical stroke, but we were surprised by the high incidence of the silent ischemic events during TAVI.
Embolization could occur during retrograde or antegrade arch catheterization, during balloon valvuloplasty or during endovalve implantation. We report a rate of new ischemic lesion of 90% in the TF approach compare with 92% in the TA approach. We were expecting a higher rate of emboli in the retrograde TF group because of the manipulation of the stiff devices into the aortic arch but antegrade TA approach did not reveal a lower rate of embolic events. Our results could help to elucidate the potential sources of embolism because there is no statistical difference between antegrade and retrograde approach in terms of mean number of embolic lesions. However, there is a statistical difference ( p = 0.02) between TAVI (groups 1 and 2) and conventional surgery (group 3) with a rate of embolism of only 7%. We observed that the volume of the lesions is higher in the TA approach (2170. ), but this was not statistically significant. The localization of the embolic lesions was also preponderant on the left cerebral hemisphere to a greater extent in the TF than in the TA group. We were expecting a higher rate of right hemisphere embolism in the TA group because, during the antegrade approach, the guiding would to go often into the right brachiocephalic trunk. Again, there is no difference in terms of the localization of the embolic lesions. Even in CG, the embolic side was the left hemisphere. Ghanem reported exactly the same results [15] with respect to CoreValve (Medtronic Inc, Minneapolis, Minnesota, USA) prosthesis implantation by the TF approach. We developed three hypotheses to understand why embolisms occur in the left hemisphere. First, position of the left subclavian artery in the arch is in the direct way of the emboli released by the sheath when it runs from the descending thoracic aorta to the aortic arch. The external curve of the device scratches the aortic wall when you push it forwards to reach the aortic valve. The second hypothesis is regarding the total amount of emboli coming from the ascending aorta. We could say that onethird is going in each supraaortic arch vessel. However, the amount of embolus going into the brachiocephalic trunc is divided into three vessels: right carotid, right vertebral, and right axillary arteries. On the other hand, one-third of emboli goes directly into the left carotid and one-third into the left vertebral artery; hence, there are more emboli in the left brain than in the right. This is just our own analysis of the problem. The third hypothesis is based on an experimental fluid mixing model published by Lutz [17] to understand why anticancer drugs do not reach the left brain and the right brain. They propose that there is a stratification of the flow even into the Willis polygone. The drug injected by the left vertebral artery is not mixed into the Willis polygone and only the left brain receives the drug, and not the right brain. So, this means that the phenomenon is complex and we need further analysis of the emboli process using, for instance, an intracranial Doppler during the procedures.
To reduce the risk of cerebral embolism during TAVI, we have to develop and use efficient protection devices. There are already some of them available on the market; but no strong data in the literature support the efficiency of those devices.
One option to reduce the risk of embolism could be the 'no touch' technique described by Bagur [16] using a TA approach to deploy the valve with no wire and no catheter manipulation in the arch. In this article, the authors assume that the embolism occurs during the aortic arch manipulation. This is an isolated case report in which silent embolic lesions were not assessed by DWI. Further studies are mandatory to prove that absence of wire in the aortic arch signifies the absence of cerebral embolization.
Study limitation
This is not a randomized trial and the number of patient included in the three groups is limited.
Regarding the control group 3, we agree that the population is younger than in groups 1 and 2. We had some difficulties to convince old people, who were eligible for AVR, to have preoperative and postoperative DW-MRI. Many of them refused because they had been already into a long preoperative work-up and they were unhappy to have surgical AVR rather than TAVI. On the other hand, old patients selected for TAVI knew that they are going to receive an expensive, less invasive, and new technique; hence, they accepted easily any additional investigations such brain DW-MRI before and after the procedure. Anyway, we still continue to further enroll older patients for further publication.
The neurological examination did not take into account neurocognitive testing. This is a clear weakness of our study, which needs to emphasized.
Conclusions
The incidence of cerebral silent embolic lesions is very high during TAVI and is similar in the TF and TA approaches.
The conventional on-pump AVR is still the 'gold standard' treatment with a lesser risk of cerebral embolization.
The impact of neurocognitive dysfunction need to be assessed in further studies.
